评论
打印
US buys up COVID-19 drug?
美国买断瑞德西韦库存？
The World Health Organization (WHO) on Wednesday voiced concerns over news reports that the US government has bought almost all the stocks of key COVID-19 drug remdesivir.
近日有报道称，美国政府几乎买断了治疗新冠肺炎的关键药物瑞德西韦的全部库存，世界卫生组织7月1日就此表示担忧。
US President Donald Trump's administration has bought up virtually all the stocks for the next three months of one of the two drugs proven to work against COVID-19, causing alarm among experts and campaigners, the Guardian reported.
据《卫报》报道，特朗普政府几乎买断了未来三个月瑞德西韦的全部库存，这引起了专家和活动人士的警觉。
Mike Ryan, executive director of the WHO Health Emergencies Program, said the WHO is aware of media reports about procurement of the remdesivir stock and is working with colleagues and partners in the COVID-19 Tools Accelerator program to verify the reports.
瑞德西韦是已得到验证、能够治疗新冠肺炎的两种药物之一。世卫组织卫生紧急项目负责人迈克尔·瑞安称，世卫组织已知晓有关买断瑞德西韦库存的媒体报道，正与"抗新冠肺炎工具加速器"项目的同事及合作伙伴一同对相关报道进行核实。
He said that "we are fully committed as an organization with our partners to equitable access to lifesaving interventions".
瑞安表示：“世卫将与合作伙伴一起，为公平分配新冠救命工具而全力以赴。”
COVID-19 cases in the US are spiraling out of control.
目前美国的新冠肺炎病例数増势正趋失控。
